Wanbury Announcements
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Wanbury...
08 Apr, 2026 | 05:06pm • Source: BSE
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
06 Apr, 2026 | 06:14pm • Source: BSE
Trading Window Closure for the last quarter and year ended 31st March, 2026.
26 Mar, 2026 | 04:37pm • Source: BSE
Press release dated 24th March, 2026.
24 Mar, 2026 | 12:38pm • Source: BSE
Wanbury Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Press Release dated 12.03.2026
12 Mar, 2026 | 10:55am • Source: NSE
Press release dated 12.03.2026
12 Mar, 2026 | 09:14am • Source: BSE
The Exchange had sought clarification from Wanbury Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure...
05 Mar, 2026 | 12:46pm • Source: NSE
Investor Presentation on Un-audited Financial Results (UFR) for the quarter and nine months ended 31st December, 2025.
09 Feb, 2026 | 10:11am • Source: BSE
Press Release on Un-audited Financial Results (UFR) for the quarter and nine months ended 31st December, 2025.
06 Feb, 2026 | 03:21pm • Source: BSE
Press Release with titled "Wanbury Achieves First Sales Invoicing and commercial shipment milestone on 30th January, 2026 for the new Product, High-Demand Anaesthetic API-Production Ramp-Up...
03 Feb, 2026 | 10:39am • Source: BSE
Wanbury Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Wanbury launches commercial production of key anaesthetic API at Tanuku...
28 Jan, 2026 | 12:16pm • Source: NSE
Wanbury Launches Commercial production of key anaesthetic API at Tanuku Facility.
28 Jan, 2026 | 11:29am • Source: BSE
Certificate under reg. 74 (5) of SEBI (DP) Reg, 2018
07 Jan, 2026 | 06:08pm • Source: BSE
Intimation under Regulation 30 and Schedule III (LODR) Regulations, 2015 on Re-appointment of Mr. Manojkumar Khubchand Gursahani (DIN: 01064558) as the Non-Executive Independent Director of...
05 Jan, 2026 | 05:44pm • Source: BSE
Summary of proceedings of Extra Ordinary General Meeting (EOGM) dated 05.01.2026.
05 Jan, 2026 | 04:24pm • Source: BSE
1. Re-Appointment of Mr. Manojkumar Khubchand Gursahani (DIN: 01064558) as a Non-Executive Independent Director.2. Approval of issuance of Notice for convening an Extra Ordinary General...
10 Dec, 2025 | 06:21pm • Source: BSE
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
01 Dec, 2025 | 12:49pm • Source: BSE
Revised Investor Presentation
24 Nov, 2025 | 02:18pm • Source: BSE